Evolva in collaboration with Roquette
The collaboration will run for up to 4.5 years and involve c. 7% of Evolva’s R&D headcount. The work will include the application of Evolva’s technology to improve fermentation routes, strain improvement and pilot scale-up.
Roquette will pay Evolva an upfront technology access fee as well as research fees during the project period. In addition, Evolva may receive milestone payments based on the extent to which certain research and commercial objectives are reached, plus potential payments based on the value created by the project. The total of technology access and milestone payments will be a single-digit CHF million amount.
Pascal Longchamp, Chief Business Officer of Evolva, said “This collaboration further validates the capability of our technology platform to impact multiple industries, and we are looking forward to working with Roquette. We share with Roquette core values in the development of sustainable processes from natural and renewable resources and we are pleased to team up with a company dedicated to exploring innovative solutions for their customers.”
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.